Hearing on American Biotechnology Leadership and a More Resilient Health Care System

This week, I chaired a Senate Finance Committee hearing on the role of biotechnology in strengthening America’s health care system, securing medical supply chains, combating emerging health threats, and ensuring the United States remains the global leader in biotechnology biotech innovation.
I spoke about my work as Chair of the National Security Commission on Emerging Biotechnology (NSCEB), discussed Indiana’s leadership in life sciences, and highlighted China's ambition for biotechnological supremacy, underscoring the need for our country to strengthen domestic innovation to maintain our competitive edge.
Additionally, I spoke about the growing threat of antimicrobial resistance and the need to spur the development of new antibiotics and other innovative therapies to bolster America's long-term health security by addressing drug-resistant infections.
To watch my opening statement, click here or the image above. See more from the hearing here. |